Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
J Neurol
.
2023 Aug;270(8):3787.
doi: 10.1007/s00415-023-11784-1.
Authors
Tobias Monschein
1
,
Sarinah Dekany
1
,
Tobias Zrzavy
1
,
Markus Ponleitner
1
,
Patrick Altmann
1
,
Gabriel Bsteh
1
,
Barbara Kornek
1
,
Paulus Rommer
1
,
Christian Enzinger
2
,
Franziska Di Pauli
3
,
Jörg Kraus
4
5
,
Thomas Berger
1
,
Fritz Leutmezer
6
,
Michael Guger
7
;
Austrian MS Treatment Registry (AMSTR)
Affiliations
1
Department of Neurology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
2
Department of Neurology, Medical University of Graz, Graz, Austria.
3
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
4
Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
5
Department of Laboratory Medicine, Paracelsus Medical University and Salzburger Landeskliniken, Salzburg, Austria.
6
Department of Neurology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
[email protected]
.
7
Clinic for Neurology 2, Kepler University Clinic, Linz, Austria.
PMID:
37272963
PMCID:
PMC10344974
DOI:
10.1007/s00415-023-11784-1
No abstract available
Publication types
Published Erratum